Search keyWord :

Prof. Gang Shen Presents Smartee S8 Orthopedic Therapy at ACAS Sydney

Sep 19, 2024

SYDNEY,Sept. 18,2024-- The Australian ClearAligner Society (ACAS) recently brought together top orthodontic experts worldwide. Among the distinguished speakers was Smartee Chief Scientist,Prof. Gang S

State grid Shizuishan power supply Company: electricity to help lighthouse new village refresh

Sep 19, 2024

SHIZUISHAN,China,Sept. 18,2024--Recently,walking into the Yaofu Town Lighthouse village beautiful livable ecological new village phase II project site,a scattered residential main project has been com

Polus Capital Management Secures ADIA Commitment for Special Situations Strategy

Sep 19, 2024

LONDON,Sept. 18,2024-- Polus Capital Management ("Polus"),a leading investment management firm specialising in alternative credit strategies,today announces that it has secured a capital com

Ampace Unveils Revolutionary Kun-Era Series Products at CIMAMotor!

Sep 19, 2024

Kun-Era Batteries,New Era for E-motorcycles CHONGQING,China,Sept. 18,2024-- On September 13,Xiamen Ampace Technology Limited (hereinafter referred to as "Ampace") proudly unveiled its ground

PRESTIGIOUS IEEE MEDAL OF HONOR PRIZE IS INCREASED TO $2 MILLION

Sep 19, 2024

The Highest Award for Exceptional Technology,Engineering,and Science Contributions Given by World\'s Largest Technical Professional Organization Now Ranks

Family Offices in Asia Pacific are Investing More in Public Equity and Fixed Income, Bullish on Private Equity: Citi Private Bank Survey

Sep 19, 2024

Annual family office survey highlights that family offices in Asia Pacific expect stronger portfolios gains in 2025

VISTA 25th Birthday Eye Carnival: A Rockin' Celebration of Vision and 25 Years of Excellence

Sep 19, 2024

PETALING JAYA,Malaysia,Sept. 19,2024-- Get ready to rock out with VISTA Eye Specialist (\'VISTA\') as we celebrate our 25th Birthday with the "See The World Like A Rockstar" Eye Carnival! Th

Transcenta Updates Encouraging Efficacy Data from First-line Triple Combo Trial of Osemitamab (TST001) for G/GEJ Cancer at ESMO 2024

Sep 19, 2024

Updated results with longer follow-up reveal confirmed ORR of 68% and median PFS of 14.2 months in patients with CLDN18.2 high or medium expression,known PD-L1 CPS (n=66).

PrintKK and Shopify Integrate for Broader Print on Demand E-commerce Solutions

Sep 19, 2024

LOS ANGELES,Sept. 18,2024-- PrintKK,a leading provider of print-on-demand solutions for e-commerce,recently announced an expanded integration with Shopify. This allows Shopify merchants to effortlessl

mecwacare selects Cognizant as strategic delivery partner to launch revolutionary digital transformation program

Sep 19, 2024

mecwacare and Cognizant embark on multi-year relationship to drive innovation and enhance experiences for mecwacare\'s workforce,clients and their families.

1 ... 972 973 974 975 976 977 978 ... 1249